Anyone discounting SURG at this point given Alcon's recent 32 million dollar settlement with them including a great licensing agreement is simply ignoring a strong buy. You can be absolutely sure new CEO David Hable with his very professional and business experienced approach will make the most out of this windfall. The stock in my opinion does not deserve to be under $3.00/share. I'm looking for a nice rise here that will take SURG into the $3.00 to $4.00 share range and then subsequently much higher. Hold on to your hats, investors, this is going to be a very nice holding for capital appreciation within the next 12 to 24 months.
i noticed june 14 is shown by yahoo as next earnings report. Should hear more about all the good news happening here. Stock is being accumulated and should break out above 3.00 soon from looks of it. Noticing nice blocks on bid side of market in lately.